In summary, our study uncovers a crucial finding that DC maturation is markedly restricted within the TME of EGFR‐mutant NSCLC, which we identified as a significant barrier to effective anti‐tumor immunity. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.